ATE336229T1 - Zusammensetzung auf der basis polymerer mizellen - Google Patents

Zusammensetzung auf der basis polymerer mizellen

Info

Publication number
ATE336229T1
ATE336229T1 AT01949161T AT01949161T ATE336229T1 AT E336229 T1 ATE336229 T1 AT E336229T1 AT 01949161 T AT01949161 T AT 01949161T AT 01949161 T AT01949161 T AT 01949161T AT E336229 T1 ATE336229 T1 AT E336229T1
Authority
AT
Austria
Prior art keywords
micellars
polymeric
composition based
therapeutic agents
including anti
Prior art date
Application number
AT01949161T
Other languages
English (en)
Inventor
Jean-Christophe Leroux
Amina Souad Benahmed
Original Assignee
Labopharm Inc
Labopharm Europe Ltd
Labopharm Barbados Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc, Labopharm Europe Ltd, Labopharm Barbados Ltd filed Critical Labopharm Inc
Application granted granted Critical
Publication of ATE336229T1 publication Critical patent/ATE336229T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT01949161T 2000-06-29 2001-06-28 Zusammensetzung auf der basis polymerer mizellen ATE336229T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/606,398 US6338859B1 (en) 2000-06-29 2000-06-29 Polymeric micelle compositions

Publications (1)

Publication Number Publication Date
ATE336229T1 true ATE336229T1 (de) 2006-09-15

Family

ID=24427804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949161T ATE336229T1 (de) 2000-06-29 2001-06-28 Zusammensetzung auf der basis polymerer mizellen

Country Status (22)

Country Link
US (1) US6338859B1 (de)
EP (1) EP1296647B1 (de)
JP (1) JP5134179B2 (de)
KR (1) KR20030039332A (de)
CN (1) CN1258358C (de)
AT (1) ATE336229T1 (de)
AU (2) AU2001270405B2 (de)
BR (1) BR0112054A (de)
CA (1) CA2414241C (de)
CZ (1) CZ302369B6 (de)
DE (1) DE60122335T2 (de)
DK (1) DK1296647T3 (de)
ES (1) ES2271039T3 (de)
HU (1) HUP0300963A2 (de)
IL (2) IL153655A0 (de)
MX (1) MXPA03000065A (de)
NO (1) NO20026255L (de)
NZ (1) NZ523645A (de)
PL (1) PL202475B1 (de)
PT (1) PT1296647E (de)
RU (1) RU2308943C2 (de)
WO (1) WO2002000194A2 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
CA2408332C (en) * 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
HUP0303719A2 (hu) * 2000-10-16 2004-03-01 Neopharm, Inc. Mitoxantron hatóanyag-tartalmú liposzómás gyógyszerkészítmények és eljárás az előállításukra
PT1343530E (pt) * 2000-11-09 2007-09-25 Astrazeneca Ab Composição farmacêutica oral contendo um copolímero de blocos
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US6780428B2 (en) * 2001-06-08 2004-08-24 Labopharm, Inc. Unimolecular polymeric micelles with an ionizable inner core
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
KR100481540B1 (ko) * 2002-02-26 2005-04-07 한국전자통신연구원 치료 약물 함유된 스마트 나노 입자의 제조 방법
US7635463B2 (en) 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
WO2003072143A1 (en) * 2002-02-27 2003-09-04 Pharmain, Ltd. Compositions for delivery of therapeutics and other materials, and methods of making and using the same
US7018655B2 (en) * 2002-03-18 2006-03-28 Labopharm, Inc. Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
US20040005351A1 (en) * 2002-03-29 2004-01-08 Kwon Glen S. Polymeric micelle formulations of hydrophobic compounds and methods
EP1393718A1 (de) * 2002-08-29 2004-03-03 OctoPlus Sciences B.V. Kolloidal Wirkstoffträgersystem
EP1581236B1 (de) * 2002-10-29 2013-10-16 Insmed Incorporated Verzögerte freisetzung von anti-infektionsmitteln
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
KR100508518B1 (ko) * 2002-11-13 2005-08-17 한미약품 주식회사 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
US7491395B2 (en) 2002-11-20 2009-02-17 Bestewil Holding B.V. Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
EP1578443B1 (de) * 2002-11-20 2011-01-12 Bestewil Holding B.V. Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung
AU2003230980A1 (en) * 2003-04-18 2004-11-26 Northeastern University Micelle delivery system loaded with a pharmaceutical agent
US7262253B2 (en) * 2003-12-02 2007-08-28 Labopharm, Inc. Process for the preparation of amphiphilic poly (N-vinyl-2-pyrrolidone) block copolymers
WO2005112977A2 (en) * 2004-04-23 2005-12-01 Pharmain, Ltd. Compositions for treatment with glucagon-like peptide, and methods of making and using the same
CN100386115C (zh) * 2004-10-14 2008-05-07 孔庆忠 一种抗癌药物组合物
US8178129B2 (en) 2004-11-02 2012-05-15 Tel-Aviv University Future Technology Development L.P. Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
CA2615939A1 (en) * 2005-08-02 2007-02-08 Miv Therapeutics Inc. Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
US7942867B2 (en) * 2005-11-09 2011-05-17 The Invention Science Fund I, Llc Remotely controlled substance delivery device
HUE029994T2 (en) 2005-12-08 2017-04-28 Insmed Inc Lipid-based compositions of antiinfectives for treating pulmonary infections
KR101529318B1 (ko) 2005-12-19 2015-06-16 파마인 코포레이션 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법
WO2007073596A1 (en) * 2005-12-27 2007-07-05 Labopharm Inc. Degradable polymeric microsphere composition
CA2650422A1 (en) * 2006-04-24 2007-11-08 Nanocarrier Co., Ltd. Process for producing polymer micelles encapsulating low molecular weight drugs
CN100434120C (zh) * 2006-09-14 2008-11-19 同济大学 两亲性荧光靶向纳米胶束及其制备方法
MX2009003092A (es) * 2006-09-22 2009-05-08 Labopharm Inc Composiciones y metodos para suministro de farmaco dirigido a ph.
WO2008073558A2 (en) * 2006-10-05 2008-06-19 The Johns Hopkins University Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
US7758635B2 (en) * 2007-02-13 2010-07-20 Boston Scientific Scimed, Inc. Medical device including cylindrical micelles
WO2008137717A1 (en) * 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US7960336B2 (en) * 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
US8563527B2 (en) * 2007-08-20 2013-10-22 Pharmain Corporation Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
US9090737B2 (en) * 2007-11-13 2015-07-28 Surmodics, Inc. Viscous terpolymers as drug delivery platform
US20090176892A1 (en) * 2008-01-09 2009-07-09 Pharmain Corporation Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
CA2635187A1 (en) 2008-06-05 2009-12-05 The Royal Institution For The Advancement Of Learning/Mcgill University Oligonucleotide duplexes and uses thereof
US9480643B2 (en) 2008-12-23 2016-11-01 Surmodics Pharmaceuticals, Inc. Implantable composites and implants comprising same
US9415197B2 (en) * 2008-12-23 2016-08-16 Surmodics, Inc. Implantable suction cup composites and implants comprising same
US8974808B2 (en) 2008-12-23 2015-03-10 Surmodics, Inc. Elastic implantable composites and implants comprising same
US8951546B2 (en) * 2008-12-23 2015-02-10 Surmodics Pharmaceuticals, Inc. Flexible implantable composites and implants comprising same
US20100168807A1 (en) * 2008-12-23 2010-07-01 Burton Kevin W Bioactive terpolymer compositions and methods of making and using same
US8524783B2 (en) 2009-04-30 2013-09-03 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
US8524784B2 (en) * 2009-04-30 2013-09-03 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
US8207290B2 (en) * 2010-03-26 2012-06-26 Cerulean Pharma Inc. Methods and systems for generating nanoparticles
US20130039864A1 (en) * 2010-04-23 2013-02-14 Francois Ravenelle Non-Intravenous Dosage Form Comprising Solid Formulation of Liquid Biologically Active Agent and Uses Thereof
WO2012030819A1 (en) 2010-08-30 2012-03-08 Surmodics Pharmaceuticals, Inc. Terpolymers as pressure-sensitive adhesives
CN101953804A (zh) * 2010-09-26 2011-01-26 苏州同科生物材料有限公司 基于两亲性嵌段共聚物的壳层可脱落式纳米药物载体制剂及其制备方法
US8546521B2 (en) 2011-01-28 2013-10-01 Cerulean Pharma Inc. Method for fabricating nanoparticles
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
SG11201401018XA (en) * 2011-10-03 2014-06-27 Univ Nanyang Tech Cationic peptidopolysaccharides with excellent broad- spectrum antimicrobial activities and high selectivity
RU2480479C1 (ru) * 2011-11-01 2013-04-27 Елена Викторовна Свирщевская Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
JP6211007B2 (ja) * 2012-02-10 2017-10-11 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ 高度ｘジブロックコポリマーの製造、精製及び使用
RU2501570C1 (ru) * 2012-05-11 2013-12-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) Трехфункциональные блоксополимеры этиленоксида и пропиленоксида для доставки активных веществ в живые клетки
MX369828B (es) 2012-05-21 2019-11-22 Insmed Inc Sistemas para tratar infecciones pulmonares.
RU2018135921A (ru) 2012-11-29 2019-02-05 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
CN104434876B (zh) * 2013-09-13 2018-04-27 布里吉·P·吉里 用于癌症疗法及成像的缺氧-标靶聚合微胞
SMT202000516T1 (it) 2014-05-15 2020-11-10 Insmed Inc Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
KR102088663B1 (ko) * 2018-03-20 2020-03-13 한국세라믹기술원 친수성 및 소수성 약물의 동시 전달을 위한 온도민감성 나노스펀지 플랫폼 및 이의 용도
EP3773505B1 (de) 2018-03-30 2026-04-29 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
WO2019213398A1 (en) 2018-05-02 2019-11-07 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
CN111592663B (zh) * 2020-03-27 2022-09-16 青岛大学 一种冠醚修饰的嵌段共聚物胶束的制备方法及其应用
CN114246831B (zh) * 2020-09-22 2024-10-15 鲁南制药集团股份有限公司 一种注射用紫杉烷类抗肿瘤药物的聚合物胶束冻干制剂
CN120346164B (zh) * 2025-06-20 2025-09-26 湖州亚瑟制药有限公司 一种环磷酰胺三元纳米胶束及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
US5817321A (en) * 1992-10-08 1998-10-06 Supratek Pharma, Inc. Biological agent compositions
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
KR100413029B1 (ko) * 1995-09-29 2004-04-30 가가쿠 기쥬츠 신코 지교단 신규안트라시클린화합물유도체및이를함유하는의약제제
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
EP1286643A2 (de) * 2000-05-17 2003-03-05 Labopharm Inc. Arzneistoff enthaltende polymere mizellen

Also Published As

Publication number Publication date
HK1059395A1 (en) 2004-07-02
NO20026255D0 (no) 2002-12-27
JP2004501180A (ja) 2004-01-15
HUP0300963A2 (hu) 2003-09-29
MXPA03000065A (es) 2004-04-02
CN1258358C (zh) 2006-06-07
PL202475B1 (pl) 2009-06-30
CA2414241A1 (en) 2002-01-03
IL153655A (en) 2008-11-26
AU2001270405B2 (en) 2005-01-20
EP1296647A2 (de) 2003-04-02
CZ302369B6 (cs) 2011-04-13
BR0112054A (pt) 2003-09-30
JP5134179B2 (ja) 2013-01-30
CZ20024268A3 (cs) 2003-05-14
DK1296647T3 (da) 2006-12-27
RU2308943C2 (ru) 2007-10-27
WO2002000194A2 (en) 2002-01-03
DE60122335T2 (de) 2007-08-30
AU7040501A (en) 2002-01-08
US6338859B1 (en) 2002-01-15
IL153655A0 (en) 2003-07-06
PL360262A1 (pl) 2004-09-06
NO20026255L (no) 2003-02-25
EP1296647B1 (de) 2006-08-16
CA2414241C (en) 2011-04-12
CN1447683A (zh) 2003-10-08
WO2002000194A3 (en) 2002-08-08
DE60122335D1 (de) 2006-09-28
PT1296647E (pt) 2006-12-29
ES2271039T3 (es) 2007-04-16
NZ523645A (en) 2004-09-24
KR20030039332A (ko) 2003-05-17

Similar Documents

Publication Publication Date Title
ATE336229T1 (de) Zusammensetzung auf der basis polymerer mizellen
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
HN2001000243A (es) Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
ATE461217T1 (de) Glp-1-verbindungen
AR027355A1 (es) Acidos tiazolidincarboxilicos
CY1106032T1 (el) Υποκατασταθεισες πυραζολες
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
SE0301653D0 (sv) Novel compounds
BR0010702A (pt) Novas quinonas como terapias de doenças
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
SE9901077D0 (sv) Novel use
DE60025639D1 (de) Substituierte diazepan
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
ITMI20031714A1 (it) Formazioni ad azione antitumorale.
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
ATE399532T1 (de) Medizinische seife
AU4558201A (en) Taxane anticancer agents
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
DE602004029453D1 (de) Auf licht reagierende duftstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1296647

Country of ref document: EP

REN Ceased due to non-payment of the annual fee